Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

EXPLAINED: 9 | Vintage Vibes

Petco Is Still Being Priced Like the Old Petco

Petco's stock fell despite flat revenue and improved margins, debt paydown, and unchanged guidance, as analysts remain mixed with a consensus Reduce rating despite price-target upside.

MarketBeat · Sep 7

How 4 Million Hewlett Packard Shares Bought an AI Network

HPE issued Oracle warrants tied to a $70 billion infrastructure deal as its networking revenue jumped 75%, even as supply chain concerns pressured shares after earnings.

MarketBeat · Sep 7

MSFT Has Gone Nowhere in 2026—Azure Says That's a Mistake

Microsoft's Azure growth accelerated to 43% and its backlog surged 84% to $678 billion, yet MSFT still trades below its five-year average forward earnings multiple.

MarketBeat · Sep 7

From analysis to the latest developments in health,
read the most diverse news in one place.

Why Franchise Models Are Winning the Restaurant Stock Divide

QSR and Yum! Brands posted strong Q2 2026 results on franchise economics and global diversification, while McDonald's U.S. sales slowed on execution missteps despite similar franchise strength.

MarketBeat · Sep 7

Palo Alto vs. Zscaler: Which Cybersecurity Stock Looks Stronger After Earnings?

Palo Alto Networks and Zscaler both beat earnings estimates this week, but Palo Alto showed faster growth and stronger free cash flow, giving it the edge over its cybersecurity rival.

MarketBeat · Sep 7

Parsons’ Pullback May Give Defense and Infrastructure Investors a Second Look

Parsons stock has fallen more than 25% YTD despite strong backlog growth and missile defense contracts, raising questions about whether the infrastructure and defense firm is undervalued.

MarketBeat · Sep 7

Powering the AI Boom: Uranium’s $95 Spark

AI-driven power demand and expiring utility contracts are tightening uranium supply, lifting long-term price targets to $95 per pound and boosting Cameco, NexGen Energy, and BWX Technologies.

MarketBeat · Sep 7

Read news from The Economist, FT, and more,
with one subscription

3 Earnings Season Winners That Analysts Can't Stop Upgrading

Elastic, John Deere, and Dynatrace all posted strong earnings and drew a wave of analyst rating upgrades and price target increases, with shares of each stock rallying in response.

MarketBeat · Sep 7

AI Token Costs Are Changing the Hardware vs. Software Debate

Rising AI token costs are pushing enterprises toward on-premises hardware, boosting Dell Technologies after strong earnings while MongoDB shares fell despite a beat, as capital rotates from cloud software to hardware.

MarketBeat · Sep 6

3 ETFs That Could Move as Rate Expectations Shift

Strong August jobs data raised rate-hike odds ahead of the Fed's September meeting. IWM, XLF, and TLT offer different ways for investors to position for the decision's outcome.

MarketBeat · Sep 6

3 Stocks With September Catalysts Investors Shouldn’t Ignore

GameStop, Apple, and Meta face key September catalysts: an earnings report, a product event, and a developer showcase that will test each company's strategy and stock narrative.

MarketBeat · Sep 6

Ollie's Bargain Outlet Stock Falls on Weak Comps Despite Margin Gains

Ollie's Bargain Outlet shares fell after weak Q2 comp sales overshadowed margin gains, store growth, and rising buybacks, with analysts maintaining a bullish Moderate Buy rating.

MarketBeat · Sep 6

Why Hewlett Packard Enterprise’s Sell-Off May Not Last

HPE's Q2 revenue rose 33.5% to $12.2 billion on AI and networking demand, beating guidance, as analysts raise price targets and forecast fresh stock highs.

MarketBeat · Sep 6

Moderna Just Doubled Overnight, and 2 More Healthcare Stocks Could Follow It

Moderna, Pharvaris and AbbVie span short, mid and long-term healthcare setups, from melanoma data to a Phase 3 catalyst and 13 straight years of dividend hikes.

MarketBeat · Sep 6

Get all your
news in one place.

100's of premium titles.
One news app.

MarketBeat · Sep 6

Can Apple's New Boss Deliver a Blockbuster Product Launch?

Apple prepares to unveil its first foldable iPhone amid rising component costs, with analysts split between a $400 bull case and a $263.66 bear case ahead of next week's launch.

MarketBeat · Sep 5

Zscaler’s Strong Quarter Still Left Investors Waiting on 1 Key Signal

Zscaler's fiscal Q4 2026 results beat estimates with 24.9% revenue growth and wider margins, while analysts raised price targets despite lingering sales leadership transition concerns.

MarketBeat · Sep 5

Is Duolingo the Next Netflix-Style Comeback Story?

Evercore upgraded Duolingo to Outperform with a $210 price target, arguing AI chatbot fears were overblown as user growth, retention, and engagement remain strong.

MarketBeat · Sep 5

GitLab’s AI Tools Are Starting to Turn Developer Demand Into Real Revenue

GitLab posted 21.3% revenue growth and beat earnings estimates in Q2 FY2027, driven by its Flex consumption pricing model, and raised its full-year adjusted earnings guidance.

Get all your
news in one place.

100's of premium titles.
One news app.

MarketBeat · Sep 5

GTA VI's Console Problem Isn't Take-Two's Problem

Take-Two shares fell despite strong GTA VI demand ahead of its Nov. 19 launch, with analysts maintaining Buy ratings and price targets implying upside, while Sony and Microsoft face console pricing and supply risks.

MarketBeat · Sep 5

Merchants Bancorp’s Rally Is Testing How Much Risk Investors Will Overlook

Merchants Bancorp shares have surged despite past credit scares and a shareholder probe, as lower credit provisions and record assets drove a strong Q2 2026 earnings beat.

MarketBeat · Sep 5

Lululemon’s Earnings Beat Hid a Bigger Problem for Its Turnaround Story

Lululemon shares fell 18% after weak Q2 2026 results and cut guidance revealed declining Americas sales, tepid China growth, and a fading turnaround narrative.

MarketBeat · Sep 5

MarketBeat Week in Review – 08/31 - 09/04

Stocks pulled back after a strong jobs report stoked rate-hike concerns. MarketBeat writers recap earnings-season themes, covering AI, cybersecurity, retail, energy, and dividend stocks.

MarketBeat · Sep 4

Revolution Medicines Got Its Breakthrough—What Moves It Next?

FDA approved Revolution Medicines' RASONQUE for pancreatic cancer, but RVMD stock stayed flat as investors had priced in the news early, with rising expenses now in focus.

MarketBeat · Sep 4

Retail Earnings Just Exposed a Bigger Divide in the U.S. Consumer Economy

Retail earnings reveal a K-shaped consumer split: Home Depot and Lowe's post solid home-improvement sales, while Walmart and Five Below face mixed results amid tariff and margin pressures.

MarketBeat · Sep 4

FB Financial's Southern Expansion and Buybacks Drive Analyst Optimism

FB Financial's earnings and loans surged after its Southern States Bancshares acquisition, with analysts issuing Buy ratings and a consensus price target implying 15% upside.

1 … 8 9 10 11

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations